1.
The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever
by Jentes, Emily S, Dr
The Lancet infectious diseases, 2011, Vol.11 (8), p.622-632

2.
Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015–16: a modelling study
by Kraemer, Moritz U G, DPhil
The Lancet infectious diseases, 2016, Vol.17 (3), p.330-338

3.
Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010
by Breugelmans, J.G
Vaccine, 2013, Vol.31 (14), p.1819-1829

4.
Protection of European domestic pigs from virulent African isolates of African swine fever virus by experimental immunisation
by King, Katherine
Vaccine, 2011, Vol.29 (28), p.4593-4600

5.
Development of vaccines against Crimean-Congo haemorrhagic fever virus
by Dowall, Stuart D
Vaccine, 2017, Vol.35 (44), p.6015-6023

6.
Yellow fever: an update
by Monath, Thomas P
The Lancet infectious diseases, 2001, Vol.1 (1), p.11-20

7.
Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease
by Barrett, Alan D.T
Vaccine, 2017, Vol.35 (44), p.5951-5955

8.
Emergence of Crimean–Congo haemorrhagic fever in Greece
by Papa, A
Clinical microbiology and infection, 2010, Vol.16 (7), p.843-847

9.
Ebola haemorrhagic fever
by Feldmann, Heinz, Dr
The Lancet (British edition), 2011, Vol.377 (9768), p.849-862

10.
Typhoid and paratyphoid fever
by Bhan, MK
The Lancet (British edition), 2005, Vol.366 (9487), p.749-762

11.
Fractional dosing of yellow fever vaccine to extend supply: a modelling study
by Wu, Joseph T, PhD
The Lancet (British edition), 2016, Vol.388 (10062), p.2904-2911

12.
Protective and immunological behavior of chimeric yellow fever dengue vaccine
by Halstead, Scott B
Vaccine, 2016, Vol.34 (14), p.1643-1647

13.
An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures
by Pereira, Renata C
Vaccine, 2015, Vol.33 (35), p.4261-4268

14.
Rift Valley Fever: An Emerging Mosquito-Borne Disease
by Linthicum, Kenneth J
Annual review of entomology, 2016, Vol.61 (1), p.395-415

15.
Typhoid fever
by Wain, John, Prof
The Lancet (British edition), 2015, Vol.385 (9973), p.1136-1145

16.
Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis
by Shearer, Freya M
The Lancet infectious diseases, 2017, Vol.17 (11), p.1209-1217

17.
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016:...
by Abate, Kalkidan Hassen
The Lancet (British edition), 2017, Vol.390 (10100), p.1260-1344

18.
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Glob...
by Abd-Allah, Foad
The Lancet (British edition), 2017, Vol.390 (10100), p.1211-1259

19.
Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited
by Ergonul, O
Clinical microbiology and infection, 2006, Vol.12 (6), p.551-554

20.
Differences between coverage of yellow fever vaccine and the first dose of measles-containing vaccine: A desk review of global data sources
by Adrien, Nedghie
Vaccine, 2019, Vol.37 (32), p.4511-4517
